Upgrade to SI Premium - Free Trial

Amid Mixed Data, Teradyne (TER) is Still Cheap; Cowen Maintains 'Outperform'

January 23, 2014 8:22 AM
Cowen & Company maintains its Outperform rating and $22 price target on Teradyne (NYSE: TER) following the company's fiscal Q413 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles